Holen Sie sich die Stockscreener-App
10.45
3.06%
0.31
Vorhandelsmarkt:
10.51
0.06
+0.57%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$10.14
Offen:
$10.5
24-Stunden-Volumen:
4.97M
Relative Volume:
1.06
Marktkapitalisierung:
$2.09B
Einnahmen:
$3.68B
Nettoeinkommen (Verlust:
$-627.00M
KGV:
-3.3199
EPS:
-3.1477
Netto-Cashflow:
$104.00M
1W Leistung:
-0.19%
1M Leistung:
+3.77%
6M Leistung:
-8.09%
1J Leistung:
-34.40%
1-Tages-Spanne:
$10.32
$10.62
1-Wochen-Bereich:
$9.75
$10.62
52-Wochen-Spanne:
$9.405
$16.96
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Compare XRAY vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
10.45 | 2.03B | 3.68B | -627.00M | 104.00M | -3.1477 |
ISRG
Intuitive Surgical Inc
|
417.07 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
145.16 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
65.84 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.09 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
193.94 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Eingeleitet | Citigroup | Sell |
| 2026-02-19 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Underweight |
| 2025-11-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
Dentsply Sirona director Brian Gladden buys $100k in stock By Investing.com - Investing.com South Africa
Dentsply Sirona director Brian Gladden buys $100k in stock - Investing.com
Betsy Holden Acquires Additional Shares of Dentsply Sirona Inc (XRAY) - GuruFocus
Dentsply Sirona director Betsy Holden buys $99,692 in stock - Investing.com UK
Director Brian P. McKeon adds 10,000 DENTSPLY SIRONA (XRAY) shares via trust purchase - Stock Titan
DENTSPLY SIRONA (XRAY) director Brian Gladden buys 9,985.022 shares at $10.015 - Stock Titan
Director at DENTSPLY SIRONA (XRAY) receives 10,000-share stock award - Stock Titan
Director Betsy Holden buys 10,086 DENTSPLY SIRONA (XRAY) shares in open market - Stock Titan
DENTSPLY SIRONA (XRAY) director Michael Barber buys 15,175 shares in open market - Stock Titan
Dentsply Sirona names John Fortson as new finance chief - Dental Tribune US
How DENTSPLY SIRONA’s New Veteran CFO Could Shape Capital Allocation and Strategy for XRAY Investors - Yahoo Finance
Dentsply Sirona Appoints John Fortson as New CFO - The Globe and Mail
Dentsply Sirona appoints new CFO - CFO Dive
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now - TradingView
Dentsply Sirona (XRAY) Appoints John Fortson as CFO - GuruFocus
Dentsply Sirona appoints John Fortson as CFO - MSN
Dentsply Sirona names John Fortson as CFO effective July 20 - Investing.com UK
Dentsply Sirona Appoints John Fortson as Chief Financial Officer - BioSpace
Dentsply Sirona Inc. Announces Appointment of John C. Fortson as Executive Vice President, Effective July 20, 2026 - marketscreener.com
Dentsply Sirona Inc. Announces Appointment of John C. Fortson as Chief Financial Officer, Effective July 20, 2026 - marketscreener.com
Dentsply Sirona names John Fortson as CFO effective July 20 By Investing.com - Investing.com South Africa
Veteran finance leader John Fortson named CFO at Dentsply Sirona (NASDAQ: XRAY) - Stock Titan
A former CEO steps in as Dentsply Sirona’s new finance chief - Stock Titan
DENTSPLY SIRONA (XRAY) 10K Form and Latest SEC Filings 2026 - MarketBeat
20%+ Collective Loss | XRAY Stock | Dentsply Sirona Inc Securities Class Action #XRAY Llamas Ruiz (JO8mC5xvnQ) - Mshale
Major dental manufacturers report resilient first quarter - Dental Tribune US
Should DENTSPLY SIRONA’s (XRAY) Nashville Digital Push Redefine Its U.S. Distribution Strategy? - Sahm
Dentsply Sirona stock held at Hold by Needham on execution risk - Investing.com
Cibc World Market Inc. Raises Stock Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders? - GuruFocus
DENTSPLY SIRONA (NASDAQ: XRAY) director logs RSU, option grants and family gifts - Stock Titan
Dentsply Sirona (XRAY) director awarded 22,822 RSUs in new equity grant - Stock Titan
DENTSPLY SIRONA (XRAY) director receives 22,822 RSUs vesting in one year - Stock Titan
DENTSPLY SIRONA Inc. (XRAY) director awarded 22,822 RSUs in new grant - Stock Titan
DENTSPLY SIRONA (XRAY) director receives 28,887-share RSU equity award - Stock Titan
DENTSPLY SIRONA (XRAY) director Mazelsky receives 22,822-share RSU equity grant - Stock Titan
Director at DENTSPLY SIRONA (XRAY) granted 22,822 RSUs - Stock Titan
Dentsply Sirona (XRAY) director awarded 22,822 RSUs vesting in one year - Stock Titan
Director Brian T. Gladden awarded RSUs in DENTSPLY SIRONA (XRAY) stock filing - Stock Titan
DENTSPLY SIRONA (XRAY) director James D. Forbes awarded 28,887 RSUs - Stock Titan
DENTSPLY SIRONA (XRAY) director awarded 22,822 RSUs, now holds 40,768 shares - Stock Titan
Kingsview Wealth Management LLC Sells 157,474 Shares of DENTSPLY SIRONA Inc. $XRAY - MarketBeat
XRAY Maintained by Barclays -- Price Target Lowered to $9.00 - GuruFocus
Shareholders at DENTSPLY SIRONA (NASDAQ: XRAY) approve 2024 incentive plan - Stock Titan
Dentsply Sirona Inc stock (US9839191015): shares edge lower after recent Q1 update - AD HOC NEWS
Dentsply (XRAY) Down 13.5% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Why digital dentistry matters: Lessons from my experience in the Amazon Rainforest - Oral Health Group
XRAY Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Dentsply Sirona Deadline Alert - TMX Newsfile
Dentsply Sirona to post Q1 earnings: What's in store for the stock? - MSN
How Dentsply Sirona’s Expanded Nashville Dental Partnership Could Impact DENTSPLY SIRONA (XRAY) Investors - Yahoo Finance
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Dentsply Sirona Inc-Aktie (XRAY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gladden Brian T | Director |
Jun 15 '26 |
Buy |
10.02 |
9,985 |
100,000 |
61,849 |
| HOLDEN BETSY D | Director |
Jun 11 '26 |
Buy |
9.88 |
10,086 |
99,692 |
87,528 |
| Barber Michael J | Director |
Jun 11 '26 |
Buy |
9.88 |
15,175 |
150,005 |
55,943 |
| LUCIER GREGORY T | Director |
Mar 09 '26 |
Buy |
12.45 |
15,000 |
186,675 |
65,000 |
| Forbes James D | Director |
Mar 09 '26 |
Buy |
12.48 |
5,000 |
62,400 |
10,000 |
| LUCIER GREGORY T | Director |
Mar 02 '26 |
Buy |
14.24 |
27,555 |
392,521 |
27,555 |
| LUCIER GREGORY T | Director |
Mar 03 '26 |
Buy |
14.03 |
22,445 |
314,858 |
50,000 |
1.68%
0.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):